ImmuCell
ICCC
16 hedge funds and large institutions have $4.13M invested in ImmuCell in 2017 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
0.01% more ownership
Funds ownership: 15.4% → 15.41% (+0.01%)
0% more funds holding
Funds holding: 16 → 16 (0)
7% less capital invested
Capital invested by funds: $4.44M → $4.13M (-$315K)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Perritt Capital Management
Chicago,
Illinois
|
+$135K |
| 2 |
BlackRock
New York
|
+$4.23K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3.08K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$61K |
| 2 |
Renaissance Technologies
New York
|
-$52.3K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$18.8K |
| 4 |
Wells Fargo
San Francisco,
California
|
-$5.75K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
HA
1
Heartland Advisors
Milwaukee,
Wisconsin
| $1.24M | – | – | – |
|
|
HP
2
HealthInvest Partners
Stockholm,
Sweden
| $931K | – | – | – |
|
|
PCM
3
Perritt Capital Management
Chicago,
Illinois
| $683K | +$135K | +23,514 | +24% |
|
|
4
Renaissance Technologies
New York
| $426K | -$52.3K | -9,100 | -11% |
|
|
SRC
5
Shufro Rose & Co
New York
| $244K | – | – | – |
|
6
Vanguard Group
Malvern,
Pennsylvania
| $186K | – | – | – |
|
|
EFS
7
Essex Financial Services
Essex,
Connecticut
| $131K | – | – | – |
|
|
8
Wells Fargo
San Francisco,
California
| $127K | -$5.75K | -1,000 | -4% |
|
|
MA
9
Minerva Advisors
Bala Cynwyd,
Pennsylvania
| $79K | – | – | – |
|
10
Morgan Stanley
New York
| $41K | – | – | – |
|
|
11
UBS Group
Zurich,
Switzerland
| $14K | -$18.8K | -3,275 | -57% |
|
12
Bank of America
Charlotte,
North Carolina
| $11K | – | – | – |
|
|
13
BlackRock
New York
| $4K | +$4.23K | +736 | New |
|
14
Royal Bank of Canada
Toronto,
Ontario, Canada
| $3K | – | – | – |
|
|
TRCT
15
Tower Research Capital (TRC)
New York
| $3K | +$3.08K | +537 | New |
|
|
16
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$61K | -10,363 | Closed |
|
ICCC Hedge Fund Activity: Q1 2017 in Review
16 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in ImmuCell (ICCC) for Q1 2017, worth a combined $4.13M — down 7.1% from $4.44M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new ICCC positions and 1 closed out — a net gain of 1 holder — while 1 added to existing stakes and 3 trimmed.
The largest buyer was Perritt Capital Management, adding an estimated $135K. The largest seller was Deutsche Bank, exiting entirely with an estimated $61K sold.
- 16 institutional investors held ImmuCell (ICCC) as of Q1 2017, unchanged from Q4 2016.
- Funds reported $4.13M of ImmuCell stock for Q1 2017, down 7.1% quarter-over-quarter.
- 2 funds opened new ImmuCell positions in Q1 2017 and 1 closed out, a net change of +1 holder.
- The largest ImmuCell buyer in Q1 2017 was Perritt Capital Management, an estimated $135K added.
- The largest ImmuCell seller in Q1 2017 was Deutsche Bank, an estimated $61K sold.
Based on aggregated 13F filings for Q1 2017.